Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

British Journal of Haematology

Volumn 112, Issue 3, 2001, Pages 820-823

  Willenbacher, Wolfgang ^a   Basara, Nadesta ^a   Blau, Igor W ^a   Fauser, Axel A ^a   Kiehl, Michael G ^a  

^a BMT Unit   (Germany)

Author keywords

BMT; Daclizumab; Graft versus host disease; GVHD; Interleukin 2 receptor antibody

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ACUTE DISEASE; ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; INFECTION COMPLICATION; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROPHYLAXIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; SKIN DISEASES; TREATMENT FAILURE;

EID: 0035107591     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02582.x     Document Type: Article

References (12)

1. Treatment of acute graft-versus-host disease with humanized anti-tac: An antibody that binds to the interleukin-2 receptor
2. Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graftversus-host prophylaxis
3. Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for the prevention of renal allograft rejection
4. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy after orthotopic liver transplantation
5. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients
6. A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A,-B, and -DR-identical unrelated donors and immunosuppression with ATG, ciclosporine, and methotrexate
7. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
8. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
9. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
10. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
11. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation; an analysis of clinical risk features and outcome
12. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia